Clinical Trial Update: Stereotactic Body Radiotherapy Plus FAK and RAF/MEK Inhibition in Advanced Pancreatic Adenocarcinoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the combination of stereotactic body radiotherapy with a FAK inhibitor and a RAF/MEK inhibitor for advanced pancreatic ad…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Snippet

Sponsor: Washington University School of Medicine | Conditions: Pancreatic Adenocarcinoma, Cancer of the Pancreas | Phase 2 | Status: RECRUITING